Arecor Therapeutics plc (LON:AREC – Get Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 36 ($0.47) and last traded at GBX 36 ($0.47), with a volume of 56446 shares trading hands. The stock had previously closed at GBX 38 ($0.50).
Arecor Therapeutics Trading Down 5.3 %
The stock has a market capitalization of £13.59 million, a P/E ratio of -1.27 and a beta of -0.18. The stock’s fifty day moving average price is GBX 47.65 and its two-hundred day moving average price is GBX 61.90. The company has a current ratio of 1.37, a quick ratio of 6.24 and a debt-to-equity ratio of 5.51.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Read More
- Five stocks we like better than Arecor Therapeutics
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- What is Forex and How Does it Work?
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- What is Insider Trading? What You Can Learn from Insider Trading
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
